MedPath
TGA Approval

Irinotecan hydrochloride injection 40 mg in 2 mL (3) (319642)

319642

Irinotecan hydrochloride injection 40 mg in 2 mL (3)

Pfizer (Perth) Pty Ltd

July 3, 2019

Medicine

Medicine

Active

Listed - Exempt

Active Ingredients

irinotecan hydrochloride trihydrate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Irinotecan hydrochloride injection 40 mg in 2 mL (3) (319642) - TGA 批准文号 | MedPath